ASX/CYV (ASX/CYV)

Australian Securities Exchange: ASX/CYV · AUD

A$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	13.7M
Revenue (ttm)	1K
Net income (ttm)	330.4M
EPS (ttm)	A$0.24
Shares out	1.4B
P/E (trailing)	0.0x
Volume	3,988
Beta	1.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1K
Net income (ttm): 330.4M
EPS (ttm): A$0.24
P/E (trailing): 0.0x
Market cap: 13.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E0

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-15

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-5.3%

Dow Jones Industrial Average+1.7%

Russell 2000+0.5%

All ASX/CYV indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

AUD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	33
Employees change	9
Employees growth	37.5%
Enterprise value	AUD -16.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	June
Founded	1984
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000478117
Last refreshed	2026-10-30
Market cap	AUD 13.7M
Next earnings date	2026-11-26
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-30
Symbol	asx/CYV
Website	https://ceryvyn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2,447.81%
FCF / EV yield	76.48%
FCF yield	-91.36%
Graham number	0.34529
Graham upside	3,352.9%
Industry forward P/E	28.82x
P/B ratio	0.46x
P/E ratio	0.04x
P/S ratio	13,679.78x
Price / tangible book value	0.46x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-1,194,700%
Pretax margin	33,023,600%
Profit margin	33,044,500%
Profit per employee	AUD 10M
Revenue per employee	AUD 30.3
ROA	-12.59%
ROA (5Y)	-71.13%
ROCE	-40.34%
ROIC	-14.98%
SBC / revenue	161,000%
Tax / revenue	-20,900%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-99.56%
Gross profit growth 3Y	-88%
Revenue growth	-99.56%
Revenue growth 10Y	-44.13%
Revenue growth 3Y	-88%
Revenue growth 5Y	-62.08%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 10,000
EBIT	AUD -11.9M
EBITDA	AUD -11.9M
EPS	AUD 0.24
FCF per share	AUD -0.01
Financing cash flow	AUD -30.9M
Free cash flow	AUD -12.5M
Free cash flow minus SBC	AUD -14.1M
Gross profit	AUD 1,000
Income taxes	AUD -209,000
Net borrowing	AUD -30.9M
Net cash flow	AUD -43.9M
Net income	AUD 330.4M
Operating cash flow minus SBC	AUD -14.1M
Operating income	AUD -11.9M
Revenue	AUD 1,000
Stock-based compensation	AUD 1.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-28.41
Book value per share	AUD 0.02
Debt / equity	0
Interest coverage	-1.08
Long-term assets	AUD 0
Long-term liabilities	AUD 0
Net cash (debt)	AUD 30M
Net cash / market cap	219.46%
Net debt / equity	-1.01
Piotroski F-Score	2
Shareholders' equity	AUD 29.6M
Tangible book value	AUD 29.6M
Tangible book value per share	AUD 0.02
Total assets	AUD 31.9M
Total cash	AUD 30M
Total debt	AUD 0
Total liabilities	AUD 2.3M
WACC	12.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	AUD 31.9M
Current liabilities	AUD 2.3M
Current ratio	13.78
Net working capital	AUD -406,000
Quick ratio	13.43
Working capital	AUD 29.6M
Working capital turnover	-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.23%
Dividend per share	AUD 0.00
Last dividend	AUD 0.15
Shareholder yield	-10.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	11.11%
1M total return	11.11%
1W price change	-9.09%
1W total return	-9.09%
20-day SMA	AUD 0.01
3M price change	-16.67%
3M total return	-16.67%
50-day SMA	AUD 0.01
52-week high	AUD 0.03
52-week high date	2026-06-03
52-week low	AUD 0.01
52-week low date	2026-09-29
All-time high	AUD 0.03
All-time high date	2026-06-03
All-time low	AUD 0.01
All-time low date	2026-09-15
Average true range (ATR)	AUD 0.00
Average volume	5.2M
Beta (1Y)	0.84
Beta (2Y)	0.74
Beta (5Y)	1.48
Change from 52-week high	-60%
Change from 52-week low	25%
Change from all-time high	-60%
Change from all-time low	25%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 39.88
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	0
Open price	AUD 0.01
Previous close	AUD 0.01
Price vs 20-day SMA	-9.91%
Price vs 50-day SMA	-5.66%
Relative volume	0
RSI	43.12
Sharpe ratio	-0.6
Sortino ratio	-0.81
Volume	4K
Weekly RSI	37.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	772.1M
Shares change (QoQ)	2.71%
Shares change (YoY)	10.23%
Shares held by insiders	20.71%
Shares held by institutions	15.15%
Shares outstanding	1.4B

Deeper analysis on ASX/CYV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/CYV report

Is a complete ASX/CYV research report available?

No complete published report is available for asx/CYV (ASX/CYV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

13.7M

Revenue (ttm)

Net income (ttm)

330.4M

EPS (ttm)

A$0.24

Shares out

1.4B

P/E (trailing)

0.0x

Volume

3,988

Beta

1.48

Metric

Value

Amount currency

AUD

Country

Australia

Country code

Earnings date

2026-11-26

Employees

Employees change

Employees growth

37.5%

Enterprise value

AUD -16.3M

Exchange

Australian Securities Exchange

Financial currency

AUD

Financial report date

2026-06-30

First seen

2026-07-12

Fiscal year end

June

Founded

1984

Industry

Biotechnology

Is primary listing

Yes

ISIN number

AU0000478117

Last refreshed

2026-10-30

Market cap

AUD 13.7M

Next earnings date

2026-11-26

Price

AUD 0.01

Price currency

AUD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-30

Symbol

asx/CYV

Website

https://ceryvyn.com

Metric

Value

Earnings yield

2,447.81%

FCF / EV yield

76.48%

FCF yield

-91.36%

Graham number

0.34529

Graham upside

3,352.9%

Industry forward P/E

28.82x

P/B ratio

0.46x

P/E ratio

0.04x

P/S ratio

13,679.78x

Price / tangible book value

0.46x

Sector forward P/E

34.28x

Metric

Value

Gross margin

100%

Operating margin

-1,194,700%

Pretax margin

33,023,600%

Profit margin

33,044,500%

Profit per employee

AUD 10M

Revenue per employee

AUD 30.3

ROA

-12.59%

ROA (5Y)

-71.13%

ROCE

-40.34%

ROIC

-14.98%

SBC / revenue

161,000%

Tax / revenue

-20,900%

Metric

Value

Gross profit growth

-99.56%

Gross profit growth 3Y

-88%

Revenue growth

-99.56%

Revenue growth 10Y

-44.13%

Revenue growth 3Y

-88%

Revenue growth 5Y

-62.08%

Metric

Value

Depreciation and amortization

AUD 10,000

EBIT

AUD -11.9M

EBITDA

AUD -11.9M

EPS

AUD 0.24

FCF per share

AUD -0.01

Financing cash flow

AUD -30.9M

Free cash flow

AUD -12.5M

Free cash flow minus SBC

AUD -14.1M

Gross profit

AUD 1,000

Income taxes

AUD -209,000

Net borrowing

AUD -30.9M

Net cash flow

AUD -43.9M

Net income

AUD 330.4M

Operating cash flow minus SBC

AUD -14.1M

Operating income

AUD -11.9M

Revenue

AUD 1,000

Stock-based compensation

AUD 1.6M

Metric

Value

Altman Z-Score

-28.41

Book value per share

AUD 0.02

Debt / equity

Interest coverage

-1.08

Long-term assets

AUD 0

Long-term liabilities

AUD 0

Net cash (debt)

AUD 30M

Net cash / market cap

219.46%

Net debt / equity

-1.01

Piotroski F-Score

Shareholders' equity

AUD 29.6M

Tangible book value

AUD 29.6M

Tangible book value per share

AUD 0.02

Total assets

AUD 31.9M

Total cash

AUD 30M

Total debt

AUD 0

Total liabilities

AUD 2.3M

WACC

12.36%

Metric

Value

Asset turnover

Current assets

AUD 31.9M

Current liabilities

AUD 2.3M

Current ratio

13.78

Net working capital

AUD -406,000

Quick ratio

13.43

Working capital

AUD 29.6M

Working capital turnover

-0

Metric

Value

Buyback yield / dilution

-10.23%

Dividend per share

AUD 0.00

Last dividend

AUD 0.15

Shareholder yield

-10.23%

Metric

Value

1D price change

1M price change

11.11%

1M total return

11.11%

1W price change

-9.09%

1W total return

-9.09%

20-day SMA

AUD 0.01

3M price change

-16.67%

3M total return

-16.67%

50-day SMA

AUD 0.01

52-week high

AUD 0.03

52-week high date

2026-06-03

52-week low

AUD 0.01

52-week low date

2026-09-29

All-time high

AUD 0.03

All-time high date

2026-06-03

All-time low

AUD 0.01

All-time low date

2026-09-15

Average true range (ATR)

AUD 0.00

Average volume

5.2M

Beta (1Y)

0.84

Beta (2Y)

0.74

Beta (5Y)

1.48

Change from 52-week high

-60%

Change from 52-week low

25%

Change from all-time high

-60%

Change from all-time low

25%

Change from open

Day's gap

Dollar volume

AUD 39.88

High price

AUD 0.01

Low price

AUD 0.01

Monthly RSI

Open price

AUD 0.01

Previous close

AUD 0.01

Price vs 20-day SMA

-9.91%

Price vs 50-day SMA

-5.66%

Relative volume

RSI

43.12

Sharpe ratio

-0.6

Sortino ratio

-0.81

Volume

Weekly RSI

37.1

Metric

Value

Float

772.1M

Shares change (QoQ)

2.71%

Shares change (YoY)

10.23%

Shares held by insiders

20.71%

Shares held by institutions

15.15%

Shares outstanding

1.4B

ASX/CYV (ASX/CYV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CYV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CYV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CYV

Frequently asked questions

ASX/CYV (ASX/CYV)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CYV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CYV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CYV

Frequently asked questions